FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Jubilant Cadista Pharmaceuticals Methylprednisolone Tablets Recall

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jub…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class III
Reported by FDA
Mar 10, 2021
Recall ID
D-0298-2021
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Methylprednisolone Tablets starting Feb 19, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0298-2021 on Mar 10, 2021. Reason: Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card. Status: Terminated.

Why it was recalled

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Product description

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

Lot numbers, UPCs & expiration codes

Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022

Where it was sold

USA nationwide, including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0298-2021
Classification
Class III
Status
Terminated
Recall initiated
Feb 19, 2021
FDA report date
Mar 10, 2021
Quantity
635,400 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0298-2021, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
87342
Address
207 Kiley Dr
Code information
Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022
Postal code
21801-2249
Report date
Mar 10, 2021
Product type
Drugs
Recall number
D-0298-2021
Classification
Class III
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
635,400 cartons
Termination date
Nov 15, 2022
Reason for recall
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
Distribution pattern
USA nationwide, including Puerto Rico.
Recall initiation date
Feb 19, 2021
Initial firm notification
Letter
Center classification date
Mar 4, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0298-2021, published Mar 10, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls